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Abstract
Introduction: Even though sepsis is one of the common causes of children morbidity and mortality, specific
inflammatory markers for identifying sepsis are less studied in children. The main aim of this study was to compare
the levels of high-mobility group box-1 protein (HMGB1), Lipopolysaccharide-binding protein (LBP), Interleukin-6
(IL-6) and C-reactive protein (CRP) between infected children without systemic inflammatory response syndrome
(SIRS) and children with severe and less severe sepsis. The second aim was to examine HMGB1, LBP, IL6 and CRP
as markers for of bacteraemia.
Methods: Totally, 140 children with suspected or proven infections admitted to the Children’s Clinical University
Hospital of Latvia during 2008 and 2009 were included. Clinical and demographical information as well as infection
focus were assessed in all patients. HMGB1, LBP, IL-6 and CRP blood samples were determined. Children with
suspected or diagnosed infections were categorized into three groups of severity of infection: (i) infected without
SIRS (n = 36), (ii) sepsis (n = 91) and, (iii) severe sepsis (n = 13). They were furthermore classified according
bacteraemia into (i) bacteremia (n = 30) and (ii) no bacteraemia (n = 74).
Results: There was no statistically significant difference in HMGB1 levels between children with different levels of
sepsis or with and without bacteraemia. The levels of LBP, IL-6 and CRP were statistically significantly higher
among patients with sepsis compared to those infected but without SIRS (p < 0.001). Furthermore, LBP, IL-6 and
CRP were significantly higher in children with severe sepsis compared to those ones with less severe sepsis (p <
0.001). Median values of LBP, IL6 and CRP were significantly higher in children with bacteraemia compared to
those without bacteraemia. The area under the receiver operating curve (ROC) for detecting bacteraemia was 0.87
for both IL6 and CRP and 0.82 for LBP, respectively.
Conclusion: Elevated levels of LBP, IL-6 and CRP were associated with a more severe level of infection in children.
Whereas LBP, IL-6 and CRP seem to be good markers to detect patients with bacteraemia, HMGB1 seem to be of
minor importance. LBP, IL-6 and CRP levels may serve as good biomarkers for identifying children with severe
sepsis and bacteraemia and, thus, may be routinely used in clinical practice.
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Sepsis in children population is one of the common
causes of morbidity and mortality in the word, with >
42 000 cases of severe sepsis in United States annually
and millions worldwide [1,2]. Hospital mortality among
USA children with severe sepsis was 10.3% [3]. In Latvia
between 1995 and 2000, 82 children with sepsis were
treated in the only tertiary level hospital in country,
with 24.4% of these cases being fatal [4]. Early recogni-
tion and prompt initiation of therapy are the most
important measures in reducing mortality from sepsis
[5-7]. The timely diagnosis of sepsis in children remains
difficult due to a variety of reasons: early warning signs
and symptoms often are non-specific, the identification
process of microorganisms in culture is prolonged.
As a milestone in clinical recognition of sepsis in chil-
dren became The International Pediatric Sepsis Consen-
sus Conference in 2002 where specific clinical
definitions of systemic inflammatory response syndrome
(SIRS) and sepsis in children were define [5].
The diagnosis of bacteraemia is still difficult due to pro-
longed time for microbiological analysis (48-72 hours) and
due to the problem that not all bacteria are detectable.
However, recent studies have revealed that some inflam-
matory markers such as the high-mobility group box-1
protein (HMGB1) [8-12], the lipopolysaccharide-binding
protein (LBP) [13-16] and the Interleukin-6 (IL-6) [17-20]
may be detectable already in the early state of infection
and bacteraemia. Whereas the findings in regard HMGB1
were inconsistent in identification of patients with infec-
tions and those without [9-12], IL-6 has been suggested to
be a suitable early inflammatory marker, with levels corre-
lating well with the severity and prognosis of sepsis
[19,20]. Increased serum LBP levels have been reported in
neonatal early onset sepsis [14], and is reported to be a
better marker in critically ill neonates and children than
other markers, such as C-reactive protein, procalcitonin
and interleukin-6 (IL-6) [15,16].
Comparatively fewer studies on inflammatory markers
in infected children as well in children with bacteraemia
have been made, lacking in numbers for LBP, HMGB1.
Taking into account the new definition of sepsis in chil-
dren [21] - systemic inflammatory response syndrome
(SIRS) with apparent or confirmed infection - there is a
clear need for accurate and rapid laboratory indicators
for the early diagnosis of bacteraemia and sepsis in chil-
dren. The main aim of this study was to compare the
levels of HMGB1, LBP, IL-6 and CRP between infected
children without systemic inflammatory response syn-
drome (SIRS) and children with sepsis of different sever-
ity levels. Furthermore, a secondary aim was to examine
the ability of HMGB1, LBP, IL6 and CRP as markers for
early detection of bacteraemia.
Methods
Material
All patients admitted to the Children’s Clinical Univer-
sity Hospital between January 2008 and May 2009
whose parents agreed to participate were included in
this study. The hospital is the only tertiary level children
hospital of Latvia that serves a population of ~420,000
children. The inclusion criteria for the study were the
suspected diagnosis of an infection by the referring phy-
sician and age from 1 week to 18 years. Exclusion cri-
teria were antibacterial therapy within the last 48 h,
immunodeficiency, chronic liver or kidney illness, vacci-
nation within 5 days before the start of the illness, any
chronic illness that alters CRP levels, congenital meta-
bolic defects, chromosomal anomalies, and use of corti-
costeroids or immunosuppressant medications.
A total of 140 patients fulfilled the entry criteria
(infection) and were enrolled. The percentage of infected
patients with sepsis based on SIRS criteria was 74% (n =
104) Patients were classified at the time of inclusion
into three following groups of severity of infection: (i)
infected without SIRS (n = 36), (ii) sepsis (n = 91) and,
(iii) severe sepsis (n = 13). They were furthermore clas-
sified according to bacteraemia into (i) patients with
bacteremia and/or high possibility of bacteraemia (n =
30) and (ii) patients without bacteraemia (n = 74).
Definition of infection
SIRS criteria were assessed, taking into account the
values of vital signs appropriate to the child’s age group,
including body temperature, heart rate, respiratory rate
and leukocyte count [21]. Classification of the status of
SIRS was done by two clinicians without knowing the
laboratory results. Sepsis was defined as systemic inflam-
matory response syndrome (SIRS) in the presence of
suspected or proven infection. The diagnose of infection
was verified thereafter by positive bacterial culture, tis-
sue strain. Furthermore, evidence of infection included
positive clinical findings, imaging or laboratory tests
(white blood cells in sterile body fluid, pneumonia in
radiographic imaging, petechial or purpuric rash) [21].
For sepsis severity definition the International Pediatric
Sepsis Consensus Conference classification was used.
Sepsis was defined as severe when the patient had one
of the following: cardiovascular dysfunction (hypoten-
sion <5
th percentile for age, or systolic blood pressure
<2SD below normal of age despite >40 ml/kg of isotonic
intravenous fluid in 1 hour) or need for vasoactive drug
to maintained blood pressure or 2 of the following:
unexplained metabolic acidosis, base deficit>5.0 mEq/L,
increased arterial lactate > 2 times upper limit of nor-
mal, oliguria (urine output <0 . 5m l / k g / h ) ,p r o l o n g e d
capillary refill > 5 sec, core to periphere temperature
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as defined by the presence of a PaO2/FiO2 ratio < 300
mm Hg, bilateral infiltrates on chest radiograph, and no
evidence of left heart failure or sepsis plus 2 or more
organ dysfunctions (respiratory, renal, neurological,
hematological or hepatic). Septic shock was defined as
sepsis and cardiovascular organ dysfunction. Multiple
Organ Dysfunction Syndrome was defined as presence
of altered organ function such that homeostasis cannot
be maintained without medical intervention [21].
Possible bacteraemia was defined based on the con-
sensus definitions for bloodstream infections in children
[22]. The definition includes the presence of SIRS and
convincing focus of bacterial infection (pulmonary infil-
trates, soft tissue infections, pyelonephritis, osteomyeli-
tis) given a negative blood culture.
Measurements
A venous blood sample was drawn from each patient
under local anesthesia induced by an EMLA patch. All
analyzes were made immediately, excepted HMGB,
where the samples were processed at frozen at -80°C
within 30 min of sampling.
Clinical and demographic data of the patients were
assessed and biochemical markers of inflammation
(HMGB1, LBP, IL-6, CRP) were determined.
Laboratory assays
HMGB1 levels were measured with a commercially
available enzyme-linked immunosorbent assay (HMGB1
ELISA kit; Shino-Test Corporation, Tokyo, Japan). The
measuring range was 1 to 80 ng/ml, the coefficient of
variation being <10%. Recovery of HMGB1 in this
ELISA was 80-120%.
IL6 and LBP were determined with a chemilumines-
cent immunometric assay Immulite® 2000 (Siemens
Medical, Germany). The analytical sensitivity for IL6
was 2 pg/ml and 0.2 μg/ml for LBP.
CRP levels were measured by the latex method
(COBAS INTEGRA; Roche professional Diagnostics),
the lowest assay sensitivity being 0.085 mg/L. CRP levels
<20 mg/L were accepted as normal.
All the laboratory analyses were carried out at the
Children Clinical University Hospital (Latvia), except for
HMGB 1 which was analyzed in the laboratory of Clini-
cal Immunology and Immunogenetic, Riga Stradins
University.
Ethical considerations
The study protocol was approved by the Central Medi-
cal Ethics Committee of Latvia. Each child’s parents
signed a written consent form. All patients had received
the standard of care according to hospital guidelines.
Statistical analyses
The data was analyzed using SPSS version 17.0 for Win-
dows and Epi Info 2000. The results are presented as
numbers (n), frequencies (%), means with respective
standard deviation (SD) and as medians with their inter-
quartile ranges (IQR). Differences in continuous vari-
ables between different groups of infections were
performed using the Kruskal - Wallis test and Mann -
Whitney tests as the continuous variables did not follow
a normal distribution. Correlation analysis was carried
out calculating the Spearman rank coefficient and the
respective p-value.
To assess the performance of the selected biomarkers
with respect to bacteraemia, receiver operating charac-
teristics (ROC) curves, sensitivity and specificity values
were calculated. The 95% confidence interval and p
value were reported for the area under the curve (AUC)
for the optimal cut-off levels. A p-value of less than 0.05
(two-tailed) was considered statistically significant for all
tests.
Results
Baseline characteristics of the study sample
The baseline characteristics of the study sample are pre-
sented in Table 1. The mean age of was 84.6 months for
the infected patients without SIRS, 70.4 months for sep-
sis patients, and 97.5 months for the severe sepsis
patients, respectively.
The number of infections according to age-groups and
infection focus can be found in table 2. The most com-
mon infections were upper and lower respiratory track
infections as well as gastroenteritis. Bacteraemia was
confirmed by 2 separate positive blood cultures. Gram-
positive bacteria were identified in 5 patients; Gram-
negative bacteria in 3 patients, patients with strongly
suspected bacteraemia without microbiological confir-
mation had pneumonia (11 children), skin/soft tissue
infections (6 children), pyelonephritis (4 children),
osteomyelitis (1 child).
Differences in levels of HMGB1, LBP, IL6 and CRP
between groups of different severity of infection
HMGB1 levels in infected patients without SIRS did
not statistically significantly differ from those with sep-
sis or sever sepsis. In addition there was no statistically
significant difference observed in HMGB1 levels
between children with sepsis and those with severe
sepsis (Table 3). LBP, IL-6 and CRP levels were signifi-
cantly higher among sepsis patients compared with
infected children without SIRS (p < 0.001) and were
significantly higher in the severe sepsis group com-
pared with the less severe sepsis group (p < 0.001 for
all differences).
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between children with and without bacteraemia
There was no statistically significant difference in HMGB1
levels between children patients with and without bactere-
mia (Table 4). However, LBP, IL-6 and CRP levels were
statistically significantly higher in bacteremic patients
compared to those without bacteraemia (p < 0.001).
Correlations between HMGB1, LBP, IL-6 and CRP in
children
No correlations were found between HMGB1 and any of
the other three biomarkers (Table 5). LBP correlated
well with IL-6 (r = 0.688, p < 0.001) and CRP (r =
0.741, p < 0.001). In addition, a strong correlation was
found between IL-6 and CRP (r = 0.632, p < 0.001).
Diagnostic abilities of HMGB1, LBP, IL6 and CRP in
detecting children with bacteremia
In receiver operating curve (ROC) analysis for detecting
bacteraemic patients, both IL6 and CRP had areas
under the curve (AUC) of 0.87 (Figure 1). The 95% con-
fidence interval (CI) was 0.78 - 0.96 for IL6 and 0.79 -
0.95 for CRP, respectively. LBP had an AUC of 0.82
(95% CI 0.73 - 0.91). The sensitivity using a cut-off
level of 26.6 μg/ml (LBP), 58.7 pg/ml (IL6) and 97 mg/l
(CRP) were 80% in all three markers (Table 6). The cor-
responding false-positive rates were 55% (LBP), 81%
(IL6) and 77% (CRP) for detecting children with
bacteraemia.
Discussion
Our study showed that the detectable levels LBP, IL-6
and CRP differ in the earl stage of infection dependent
on severity of infection. Furthermore, the detectable
levels of these biomarkers differ in children with bacter-
aemia and those without. In addition, our results
showed that LBP, IL-6 and CRP can be used as biomar-
kers in early detection of bacteraemia.
To date only a few studies are available on the asso-
ciation between SIRS and sepsis in children as the defi-
nitions of SIRS and sepsis in children have only recently
been adopted.
The inflammatory biomarkers - CRP, IL-6 in children
population have been studied comparatively widely, clin-
ical studies of LBP in children are limited and to our
knowledge HMGB1 have not been studied in infected
children population [14-18]. The previous studies in
children population are performed in very restricted
patients’ populations - mainly neonatal age, which have
very age specific physiological conditions with possible
influence on results; severe ill patients from intensive
care units. Our study, however, included children from
all-age groups covering a large spectrum of children
with different grades of infections.
Table 1 Baseline characteristics of the study sample according to severity of infection.
Infected patients without SIRS
(n = 36)
Sepsis patients
(n = 91)
Severe sepsis patients
(n = 13)
Boys (n) 20 49 11
Girls (n) 16 42 2
Age (months) 84.6 ± 77.0
1 70.4 ± 69.7 97.5 ± 88.2
Number of days of symptoms at hospital admission 3.8 ± 2.4 3.3 ± 2.5 2.9 ± 1.8
Number of day of symptoms at study entry 5.5 ± 3.2 4.5 ± 3.0 3.8 ± 2.0
Treatment time in the hospital (days) 6.3 ± 4.2 8.6 ± 5.9 15.4 ± 13.5
1mean ± standard deviation.
Table 2 Age groups and characteristics of infections
among children according to severity of sepsis.
Infected patients
without SIRS
1
(n = 36)
Sepsis
patients
(n = 91)
Severe sepsis
patients
(n = 13)
Age group
0 days – 1 week 0 0 0
1 week to 1
month
14 1
1 month to 1
year
72 3 2
2 to 5 years 11 30 4
6 to 12 years 6 15 0
13 to < 18 years 11 19 6
Infection focus
Upper respiratory
tract
13 39 -
Lower respiratory
tract
82 7 7
Gastroenteritis 11 13 -
Pyelonephritis - 4 -
Skin/Soft tissue
infection
-4 3
Osteomyelitis - 2 1
Meningitis - - 2
Occult
bacteremia
-2 -
Cistitis 4 - -
Total 36 91 13
1systemic inflammatory response syndrome.
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nosis of bacteraemia, as the recognition process of
pathogen in the blood is still not perfect. Frequently
bacteraemis is strongly suspected without microbiologi-
cal confirmation and physician institutes the treatment
as for bacteraemeic patient. To improve the diagnosis of
possible bacteraemia by inflammatory markers, and
speed the sequential start of appropriate treatment, we
include patients with the high suspicions of bacterial
infection (probable bacteraemia) in the group of bacter-
aemic patients. It is possible that besides gold standard -
positive blood culture, the inflammatory biomarkers
could speed the diagnosis of bacteraemia. The conse-
quential of it, is the heterogeneity of the bacteraemic
patients group, which could be evaluate as the
drawback.
HMGB1 has been known from many years as chromo-
somal protein, but in recent years it has been very
intensively investigated as a proinflammatory cytokine
[9,23]. In 1999, Wang et al [24] found increased levels
of HMGB1 in 25 critically ill patients with sepsis, and
significantly higher levels in those that succumbed to
the disease. Similar findings were reported by Hatada et
al. [11] who detected moderately elevated HMGB1 levels
in patients with infectious diseases and highest HMGB1
levels in patients who died. Gaini et al. [10] maintained
that HMGB1 levels failed to discriminate between inter-
nal medicine department patients with infection and
Table 3 Levels of HMGB1, LBP, IL-6 and CRP in infected children without SIRS, with sepsis and with severe sepsis.
Biomarker Infected patients without SIRS
(n = 36)
Sepsis patients
(n = 91)
Severe sepsis patients
(n = 13)
p-value
a
HMGB1 (ng/ml)
Median 2.5 3.0 3.1 NS
IQR 0.3-5.9 1.0-7.3 1.3-14.3
p-value
b NS NS
Lipopolysaccharide–binding protein (μg/ml)
Median 14.7 26.4 79.7 < 0.001
IQR 8.7-26.0 17.5-42.2 57.8-90.6
p-value < 0.001 < 0.001
Interleukin 6 (pg/ml)
Median 8.9 32.1 290.0 < 0.001
IQR 4.0–18.8 13.8-68.1 67.9-522.6
p-value
b < 0.001 < 0.001
C-reactive protein (mg/l)
Median 12.0 63.0 211.8 < 0.001
IQR 3.1-36.6 27.0-114.5 108.0-318.6
p-value
b < 0.001 < 0.001
Data presented as median and interquartile range (IQR). SIRS, systemic inflammatory response syndrome. HMGB1, high mobility box-1 protein; LBP,
lipopolysaccharide-binding proteine; IL-6, interleukine-6; CRP, C-reactive protein. NS, not significant.
aKruskal-Wallis tests.
b Mann Whitney two independent
sample tests, compared with the previous group in the table.
Table 4 Levels of HMGB1, LBP, IL-6 and CRP in children with and without bacteraemia.
Biomarker Infection without bacteraemia (n = 74) Infection with bacteraemia
(n = 30)
p-value
1
HMGB1
2 (ng/ml) 3.0 (1 – 7.4)
6 3.2 (1.2 – 10.9) ns
7
LBP
3(μg/ml) 23.7 (16.6 – 38.5) 63.4 (28.3 – 86) < 0.001
IL-6
4 (pg/ml) 21.2 (10.5 – 46.6) 178.1 (62.3 – 464.8) < 0.001
CRP
5 (mg/l) 54.5 (16.1 – 91.1) 212.8 (100.7 – 247.4) < 0.001
1Mann - Whitney test.;
2high mobility box-1 protein;
3lipopolysaccharide-binding proteine;
4interleukine-6;
5C-reactive protein;
6median and interquartile range
(IQR).
7not significant.
Table 5 Correlations between HMGB1, LBP, IL-6 and CRP in children with infections
HMGB1 versus marker Spearman’s P value LBP versus marker Spearman’sr P value IL6 versus marker Spearman’sr P value
LBP 0.013 0,899
1 HMGB1 0.013 0,899 HMGB1 0.115 0,243
IL6 0.115 0,243
1 IL6 0.688 < 0.001 LBP 0.688 < 0.001
CRP 0.045 0,652
1 CRP 0.741 < 0.001 CRP 0.632 < 0.001
1not significant.
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cantly higher in patients compared with healthy con-
trols. Similar findings were reported by Sunden-Cullberg
et al. [25], who noted high HMGB1 levels in patients
with sepsis and septic shock, but found no correlation
between HMGB1 concentration and the severity of ill-
ness. Angus et al. [26] found that HMGB1 levels did not
differ between those with and without sepsis. One possi-
ble explanation for these divergent results could be the
different laboratory methods used (Western blot and
ELISA). Several authors [8,27] have stated that in studies
where blotting methods were used, higher levels of
HMGB1 in range from 84 ng/ml to over 340 ng/ml
were observed [9,25,26]. Using HMGB1 ELISA
techniques, markedly lower HMGB1 levels were found.
Hatada et al. [11] observed median HMGB1 levels of 4.5
ng/ml] in infected patients. HMGB1 levels of 7.7 ng/ml
were measured by Yasuda et al. [28] in infected patients
with severe pancreatitis. Gaini et al, [10] in infected
patients without sepsis in one of their studies noted
median HMGB1 levels of 2.41 ng/ml, and median levels
of 3.4 ng/ml in another study [12] which is compara-
tively close to our HMGB1 result in this patients’ group
- 2.5 ng/ml. Mean levels of HMGB1 in sepsis patients in
our study was 3.0 ng/ml, which are in line with the
HMGB1 levels in sepsis patients found in the studies by
Gaini et al [10,12]. Furthermore, we did not found a sig-
nificant difference between HMGB1 levels in infected
patients without SIRS and patients with sepsis. These
findings are in line with those from Gaini et al [12] as
well. In our study using an ELISA technique, median
HMGB1 levels were 2.5-3.2 ng/ml which correlate with
the lower HMGB1 levels observed in others studies
where ELISA technique was used. In contrast to another
study [12], we did not found a significant difference
between HMBG1 levels in bacteraemic and non bacter-
aemic patients. This may be due to the fact that in our
Figure 1 Receiver operating curves (ROC) of LBP, IL-6 and CRP in detecting bacteraemia in children. LBP, lipopolysaccharide-binding
proteine; IL-6, interleukin-6; CRP, C-reactive protein (p < 0.001).
Table 6 Sensitivity and specificity of LBP, IL-6 and CRP
according to the optimal cut-off levels in detecting
children with bacteraemia.
Marker Cut-off level Sensitivity (%) Specificity (%)
LBP
1 26.6 μg/ml 80 55
IL-6
2 58.7 pg/ml 80 81
CRP
3 97 mg/l 80 77
1lipopolysaccharide-binding protein;
2interleukin-6;
3C-reactive protein
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with possible bacteraemia were considered as having
bacteraemia introducing a misclassification bias.
A n o t h e rp o s s i b l ee x p l a n a t i o nm a yb et h ed i f f e r e n ta g e
o ft h ec h i l d r e ni no u rs t u d yc o m p a r e dt ot h eo n ec o n -
ducted by Gaini et al. The HMGB1 is a “late onset”
proinflammatory cytokine, but our population was
sampled at the early stage of disease. This may be a rea-
son for not finding a significant difference in HMBG1
levels in our study groups.
LBP is a comparatively recently identified protein
synthesized mainly in liver. It binds to lipopolysacchar-
ide of Gram negative bacteria, and elevated levels have
been seen in infections caused by Gram positive bacteria
both in adult [29,30] and children populations [15]. We
found a moderate correlation between LBP and CRP,
which concurs with the findings of Gaini et al. [12] and
partly with their findings in their other publication
where a strong correlation was found [31]. We saw a
moderate correlation between LBP and IL6, which was
also found by Gaini and collegues[31]. In their other
study [12], these authors noted a weak correlation
between LBP and IL6. In our study LBP levels in sepsis
patients (median 26.4 μg/ml) correlates very closely with
data from Pavcnik-Arnol [16] where LBP concentrations
in SIRS patients with sepsis from population of critically
ill neonates were 27.1 μg/ml. Gaini et al. in their studies
in sepsis patients accordingly observed LBP levels of
33.5 μg/ml and 63.3 μg/ml [10,12]. In our study patients
with severe sepsis median LBP level was 79.7 μg/ml
which correlate with Gaini et al. [12] results - LBP levels
in severe sepsis patients were 88.7 μg/ml. The levels of
LBP were significantly different among infected patients
with SIRS and sepsis patients, as well among severe sep-
sis and sepsis patients which correspondent to the find-
ings from Gaini et al. studies [10,12,31]. In our study
LBP levels were significantly different among patients
with bacteraemia and without bacteraemia, these results
are in line with findings by Gaini et al. [12]. In our
study LBP with an AUC of 0.82 performed well on ROC
analysis to examine diagnostic abilities in detecting bac-
teraemia, which correlates with the study by Pavcnik-
Arnol et al. [32] where AUC values for LBP in diagnosis
of bacterial sepsis were 0.82 in older children, 0.93 in
neonates over 48 h and 0.97 in neonates aged under 48
h. LBP in Gaini at al. [12] study in adult patients popu-
lation with AUC of 0.74 did not perform well in ROC
analysis examining its ability to identify bacteraemic
patients. In our study using a cut-off level of 26.6 μg/ml,
LBP had a sensitivity of 80% and a specificity of 55.4%
in diagnosis of bacteraemia which rather correlates with
a cut-off level for LBP of 20 μg/ml with 91% sensitivity
and 85% specificity by Pavcnik-Arnol [16] in neonates
<48 h of age and cutoff 13.3 mg/l for children age.
The levels of the inflammatory cytokine IL6 in our
study showed statistically significant differences between
infected patients without SIRS and sepsis patients: IL6
was markedly higher in sepsis patients than in patients
without SIRS. Overall these results match those of other
studies analyzing the levels of IL6 in infected patients
without SIRS and sepsis in surgery patients, neonatal
age patients, children with acute apendicitis [33-36].
The median levels of IL6 were significantly different
among infected patients with SIRS and sepsis patients,
and among severe sepsis and sepsis patients, these
results correlate Gaini et al. studies [10,12,31]. Median
IL6 level for severe sepsis patients in our study was 290
pg/ml, which correlate with the median IL6 levels from
Gaini et al. [31], where medium IL6 levels were 199.3
pg/ml for severe sepsis. We found significant difference
in IL6 levels among bacteraemic and non bacteraemic
patients. IL6 levels 21.2 pg/ml and 178.1 pg/ml accord-
ingly were detected, Gaini et al. [12] observed accord-
ingly 50.3 pg/ml and 178.1 pg/ml in the same patients’
groups. We detected a moderate correlation between IL
6 and LBP which is partly consistent with findings from
other studies, where in one study a weak correlation
was detected and in another a moderate connection was
fixed [12,31]. In diagnosing bacteraemia we obtained a
cut-off level of 58.7 pg/ml for IL-6 with a sensitivity of
80% and a specificity of 55.4%. Our result is in contrast
to results by Pavcnik-Arnol [16] who reported a cut-off
of 43.2 pg/ml for bacterial neonatal sepsis diagnosis and
Silveira et al. [36] who found an optimal cut-off of 32
pg/ml for neonatal sepsis diagnosis on one side, and a
cut-off value of 94.6 pg/ml from Gaini et al. [12] in
diagnosing bacteraemia in adult population from
another side. In our study on ROC analysis IL-6 per-
formed good, with AUC 0.87, which is quite close to
results of Groselj-Grenc [33] - AUC 0.776 for acute
appendicitis diagnosis in children, and marginally differ-
ent from results in Pavcnik-Arnol [16] study - AUC
0.67 for prediction of bacterial sepsis in neonates.
The statistically significant differences in median CRP
levels observed between the three groups of children
with different severity of infection were in line with the
findings of other studies showing higher CRP levels with
higher severity of infection in children [31,37].
Naturally, our study had some limitations. The num-
ber of patients was rather small due to refusal of study
participants (29 patients refused to participate) and the
lack of a control group. Furthermore, we included
patients with strong suspected (but not confirmed) bac-
teraemia into the group with bacteraemia which may
have caused misclassification bias. However, in clinical
work this group would be considered as having bacter-
aemia and would receive adequate treatment reflecting
the real situation in clinical practice.
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included in the study, necessity of a control group con-
sisting of healthy children, and the inclusion of children
in the newborn age group. We have recognized the
potential problems which we have to meet in future: dif-
ficulties to establish the control group - to receive the
agreement from parents to take intravenous blood sam-
ples from healthy children will be complicated; difficul-
ties to include newborn children in study due to local
health-care system (newborn treatment is mainly orga-
nized in specialized centers at maternity departments).
We have focused on research results that may be useful
in future clinical practice for early severe infections
diagnosis in children by using effective diagnostic
markers.
Conclusions
The severity of an infection and bacteraemia seem to be
associated with increased inflammatory markers levels in
children with SIRS. Elevated levels of LBP, IL-6 and
CRP were associated with a more severe level of infec-
tion in children. Whereas LBP, IL-6 and CRP seem to
be good markers to detect patients with bacteraemia,
HMGB1 seem to be of minor importance and does not
seem to have a diagnostic value in differentiating bacter-
aemic patients from those without bacteraemia. LBP, IL-
6 and CRP levels may serve as good biomarkers for
identifying children with severe sepsis and bacteraemia
and, thus, may be routinely used in clinical practice.
Key messages
￿ The role of HMGB1 as inflammatory cytokine in
children has not been thoroughly explored. In our
study levels of HMGB1 were not statistically higher
in sepsis patients and HMGB1 did not enable to
detect bacteraemia in children.
￿ LBP, IL-6 and CRP levels are associated with the
severity of infection in children population.
￿ IL-6 and CRP are probably the best markers of
bacteraemia in children.
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